Farringdon Capital, Ltd. Jazz Pharmaceuticals PLC Transaction History
Farringdon Capital, Ltd.
- $198 Billion
- Q1 2025
A detailed history of Farringdon Capital, Ltd. transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Farringdon Capital, Ltd. holds 6,290 shares of JAZZ stock, worth $685,484. This represents 0.39% of its overall portfolio holdings.
Number of Shares
6,290Holding current value
$685,484% of portfolio
0.39%Shares
1 transactions
Others Institutions Holding JAZZ
# of Institutions
596Shares Held
60.5MCall Options Held
424KPut Options Held
190K-
Black Rock Inc. New York, NY6.15MShares$670 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.02MShares$656 Million0.01% of portfolio
-
Lsv Asset Management Chicago, IL2.47MShares$269 Million0.73% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.33MShares$254 Million0.07% of portfolio
-
State Street Corp Boston, MA1.97MShares$214 Million0.01% of portfolio
About Jazz Pharmaceuticals plc
- Ticker JAZZ
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,680,700
- Market Cap $6.83B
- Description
- Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...